newsfilter
← Latest News
Business Wire·

CytRx Corporation Announces Closing of $10 Million Offering to Healthcare-Focused Institutional Investor

CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced the closing of its previously announced sal